Niquitin Mint (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Niquitin Mint, is a nicotine replacement therapy presented as an oral formulation for mouth use. It helps adults who are trying to quit smoking by reducing withdrawal symptoms and cravings.

GNH USA supplies Niquitin Mint as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin Mint is a nicotine replacement therapy that addresses nicotine dependence and supports smoking cessation.

- Smoking cessation: helps adults stop smoking by alleviating cravings and withdrawal symptoms. - Nicotine dependence: reduces the physiological need for nicotine during the quitting process. - Tobacco use disorder: assists in managing habitual tobacco use by providing controlled nicotine exposure.

Niquitin Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness: discomfort in the oral cavity. - Nausea or upset stomach: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: temporary light‑headedness. - Insomnia: difficulty falling or staying asleep. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain or palpitations: signs of cardiovascular stress. - Severe hypotension: marked drop in blood pressure requiring medical attention.

Before using Niquitin Mint, consider the following safety measures.

- Assess cardiovascular status: evaluate recent heart attack or unstable angina. - Avoid use in uncontrolled hypertension: monitor blood pressure regularly. - Do not combine with other nicotine products: risk of nicotine overdose. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Niquitin Mint can interact with several medications; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase blood pressure. - CYP2A6 inhibitors: can raise nicotine plasma levels. - Other nicotine replacement products: risk of nicotine toxicity.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): monitor for mood changes. - Antihypertensive agents: nicotine may counteract blood‑pressure‑lowering effects. - Alcohol: may enhance side‑effects such as dizziness or nausea.